Major global pharmaceutical companies traded lower in the premarket on Tuesday after President Donald Trump reiterated his ...

Aries Wealth Management has tiptoed into biotech by acquiring 605 shares of Vertex Pharmaceuticals, valued around $293,000. Other hedge funds also took notice, adjusting their positions during the ...

Sage Therapeutics Inc. has found itself a buyer that bested the unsolicited acquisition offer a few months ago from fellow ...

The United States market remained flat over the last week but has experienced a 9.9% increase over the past year, with earnings forecasted to grow by 14% annually. In this context, identifying stocks ...